Vertical: CNMBase Year: 2025
Market Size (2025)
$1.02B
Projected (2032)
$1.92B
CAGR (2022–2032)
9.5%
Key Players
16+
The global microbial soil conditioners market was valued at US$ 1,018.2 Mn in 2025, up from US$ 773.5 Mn in 2022. The market is projected to reach US$ 1,115.4 Mn in 2026 and US$ 1,916.0 Mn by 2032, registering a CAGR of 9.4% during 2026–2032. Between 2025 and 2032, the market is expected to add US$ 897.8 Mn in value.
Key Findings
Bacterial products lead, fungal products grow faster. Bacterial products held 60.0% of the market in 2025. Fungal products, mainly mycorrhizal and Trichoderma-based, are projected to grow at 10.1%, compared with 9.0% for bacterial products, raising the fungal share to 41.8% by 2032.
Fruits & vegetables is the largest crop segment. High-value horticulture accounted for 45.0% of demand in 2025, because growers of these crops are more willing to pay for input quality and yield consistency. The Others segment, which includes oilseeds and pulses, is projected to grow fastest (10.0%), supported by soybean inoculation in Latin America.
Liquid formulations are gaining share. Liquid products accounted for 55.0% of the market in 2025 and are projected to grow at 10.0%. They fit seed treatment, in-furrow application, fertigation and drip irrigation.
Asia Pacific is the largest region. Asia Pacific accounted for 40.0% of the global market in 2025, led by China (US$ 171.1 Mn) and India (US$ 89.6 Mn).
Emerging regions are growing fastest. Middle East & Africa (10.8%) and Latin America (10.3%) are projected to grow fastest. North America is projected to grow at 8.2%, the slowest rate among the regions.
Policy support is widening. The EU Fertilising Products Regulation, Brazil's bioinputs law (Law No. 15,070 of December 2024), India's National Mission on Natural Farming and Japan's MIDORI strategy all support lower synthetic-fertiliser use and give biological inputs a clearer route to market.
The Microbial Soil Conditioners Market market is projected to grow at a CAGR of 9.5% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Definition
Microbial soil conditioners are products containing live, beneficial microorganisms that are applied to soil, seed or the root zone to improve soil biological activity, soil structure and nutrient availability to crops. Unlike mineral soil conditioners such as gypsum or lime, or bulk organic amendments such as compost and manure, microbial soil conditioners act primarily through the metabolic activity of the organisms they contain. These organisms fix atmospheric nitrogen, solubilise bound phosphorus and potassium, produce plant growth-promoting compounds, extend the effective root absorption zone, and secrete polysaccharides and proteins that bind soil particles into stable aggregates.
The market covers bacterial products (for example, formulations based on Bacillus, Pseudomonas, Rhizobium/Bradyrhizobium, Azospirillum and Azotobacter) and fungal products (for example, arbuscular mycorrhizal fungi, Trichoderma and phosphate-solubilising fungi such as Penicillium bilaiae). Products are supplied in liquid and dry forms and are applied across fruits and vegetables, cereals and grains, and other crops.
Report Scope
This report estimates the size of the global microbial soil conditioners market in value terms (US$ Million) for 2022–2032, with 2025 as the base year, 2022–2024 as the historical period and 2026–2032 as the forecast period. Growth rates are expressed as compound annual growth rates (CAGR) for 2026–2032.
Research Approach
Market values were estimated for each country and sub-region and then summed to give regional and global totals. Each country market was divided by microorganism type, crop type and physical form, so that segment totals reconcile with the country, regional and global totals in every year from 2022 to 2032. The analysis of market drivers, regulation and competition draws on public information, including government policy documents, regulatory texts and company announcements.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Structure
The microbial soil conditioners market is fragmented. Multinational crop-input companies with biological portfolios compete with specialised biologicals and fermentation companies and with a large number of regional and local producers, particularly in China, India and Brazil. In premium segments such as mycorrhizal inoculants, proprietary multi-strain consortia and seed-applied nitrogen-fixing microbes, competition depends on strain intellectual property, field trial data, registrations, formulation technology and access to distribution. In basic bacterial biofertilisers, price and local availability matter more.
Leading Companies
The following companies are among the active participants in the market for microbial soil conditioners and related microbial crop inputs. They are listed in alphabetical order, which does not indicate market position.
Competitive Strategies
Portfolio building through acquisitions and licensing: Large crop-input companies are acquiring specialist biologicals companies or licensing their technologies to fill portfolio gaps and use their own global distribution.
Bundling with seed and fertiliser offerings: Selling microbial products as seed treatments, fertiliser coatings or parts of crop programmes makes adoption simpler and increases the number of products sold per hectare.
Investment in field evidence: Companies are expanding multi-location, multi-season trials and using digital agronomy tools to show return on investment across different soils and climates.
Localisation: Producers are developing region-specific strains and formulations and building local fermentation capacity, particularly in Brazil and India, to improve performance and reduce cost.
Threat of new entrants: Moderate; Entry costs for basic bacterial products are relatively low, and many regional producers exist. Scale, proprietary strains, field trial data, registrations and distribution access are significant barriers in premium segments.
Bargaining power of suppliers: Low to Moderate; Fermentation media, carriers and packaging are widely available. Proprietary strain libraries and specialised mycorrhizal production capacity are concentrated among a few companies.
Bargaining power of buyers: Moderate to High; Large distributors, cooperatives and fertiliser companies can negotiate on price. Growers can switch products easily, particularly in commodity crops.
Threat of substitutes: Moderate; Mineral fertilisers, compost, manure, humic and fulvic products, and non-microbial biostimulants compete for the same input budget. Microbial products differ in that they deliver biological functions such as nitrogen fixation and mycorrhizal colonisation.
Competitive rivalry: High; The market is fragmented and includes multinational crop-input companies, specialised biologicals companies and numerous regional producers. Acquisitions and partnerships are increasing concentration in premium segments.
Market estimates by geography (2032)
InsightAsia Pacific leads with $773.30M by 2032, while Middle East & Africa is projected to grow fastest at a 10.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $143.18M | $214.99M | $318.06M | 8.3% | 17% |
| Europe | $155.69M | $243.08M | $376.50M | 9.2% | 20% |
| Asia Pacific | $307.43M | $489.95M | $773.30M | 9.7% | 40% |
| Latin America | $136.27M | $223.54M | $365.00M | 10.4% | 19% |
| Middle East & Africa | $30.94M | $49.96M | $83.15M | 10.4% | 4% |
| Total | $773.51M | $1.22B | $1.92B | 9.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.92B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Bacterial | $1.12B | 9.1% | 58% |
| Fungal | $799.93M | 10.1% | 42% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Microbial Soil Conditioners Market covering market dynamics, competitive landscape, and strategic outlook.
The Microbial Soil Conditioners Market market is projected to reach $1.92B by 2032, growing at 9.5% CAGR. The Bacterial segment holds the largest share.
Demand for microbial soil conditioners is shaped by the condition of agricultural soils, the cost and environmental impact of synthetic fertilisers, the regulatory treatment of biological inputs, and growers' experience with product performance in the field. This chapter covers the main drivers, restraints, opportunities, challenges and trends.
Soil degradation and loss of soil organic matter
The FAO's Status of the World's Soil Resources assessment reported that about one-third of the world's soils are moderately to highly degraded through erosion, nutrient depletion, loss of organic carbon, salinisation and compaction. Intensive tillage, monocropping and heavy reliance on mineral fertilisers have reduced microbial diversity and biomass in many cropping systems. Microbial soil conditioners help restore biological function in these soils: they improve aggregate stability, increase water infiltration and retention, and make nutrients more available. This has made them part of soil-health and regenerative agriculture programmes promoted by governments, food companies and farmer organisations.
Policy targets to reduce synthetic fertiliser use and nutrient losses
Several major agricultural economies have set explicit targets to reduce chemical fertiliser use. The EU Farm to Fork Strategy aims to reduce nutrient losses by at least 50% and fertiliser use by at least 20% by 2030. China's action plan for zero growth in fertiliser use, launched in 2015, encourages organic and microbial fertilisers. Japan's MIDORI Strategy for Sustainable Food Systems targets a 30% reduction in chemical fertiliser use and an expansion of organic farming to about 1 million hectares (around 25% of farmland) by 2050. In India, the National Mission on Natural Farming, launched in November 2024 with an outlay of Rs 2,481 crore, aims to bring 7.5 lakh hectares under natural farming and to set up 10,000 Bio-input Resource Centres. All of these targets create demand for inputs that improve nutrient-use efficiency without adding synthetic nutrients.
Fertiliser price volatility and nutrient-use efficiency
Nitrogen, phosphate and potash prices rose sharply in 2021–2022 because of high natural gas prices, export restrictions and supply disruptions. This showed how exposed farm margins are to mineral fertiliser costs. Microbial products that fix nitrogen or solubilise phosphorus let growers recover more value from applied and native soil nutrients. Where field results support it, growers can also reduce application rates. In the U.S., nitrogen-fixing microbial products for corn have shown that microbial inputs can replace part of the synthetic nitrogen in large-scale row crops.
Growth of high-value horticulture and organic production
Fruit, vegetable, vineyard and greenhouse growers use microbial soil conditioners to improve transplant establishment, root development, nutrient uptake and crop uniformity. Export-oriented horticulture in Mexico, Spain, Italy, Chile, Peru, Morocco and Kenya is subject to retailer requirements on residues and sustainability, which encourages biological inputs. Certified organic producers have limited options for supplying nutrients and are a stable customer base for microbial products.
Clearer regulatory pathways
Clearer regulation is lowering barriers to market entry. Since 16 July 2022, the EU Fertilising Products Regulation (EU) 2019/1009 has allowed microbial plant biostimulants based on listed microorganisms (Azotobacter spp., mycorrhizal fungi, Rhizobium spp. and Azospirillum spp.) to carry the CE mark and be sold across the EU single market. The European Commission can add microorganisms to the list through delegated acts. Brazil's Law No. 15,070 of 23 December 2024 created a dedicated legal framework for the production, import, sale and use of bioinputs, including rules for on-farm production. In the U.S., the Plant Biostimulant Act was reintroduced in Congress in May 2025 to establish a uniform federal definition and regulatory pathway.
Microbial consortia and combined products: Products that combine bacterial and fungal strains, or that combine microbes with biostimulants, humic substances or fertilisers, can deliver several functions in one application and offer a basis for differentiation.
Integration with fertiliser and seed programmes: Fertiliser manufacturers, blenders and seed companies are adding microbial products to their seed treatments, fertiliser coatings and bundled crop programmes. This gives microbial products access to established distribution and agronomy networks.
Soil carbon and sustainability programmes: Mycorrhizal and soil-structure-improving products are being linked to soil carbon programmes. In July 2026, Syngenta and Groundwork BioAg announced a partnership under which Syngenta will market Groundwork BioAg's mycorrhizal technology, alongside a soil carbon programme launching in Latin America and Europe.
Under-served emerging markets: India, Southeast Asia, Sub-Saharan Africa and the Middle East have large areas of degraded or low-organic-matter soils and supportive policy frameworks, but microbial products are still used on relatively little of their farmland.
Advances in strain discovery: Genomic sequencing, high-throughput screening and better fermentation and formulation technologies are shortening development cycles, extending shelf life and improving consistency in the field.
Variable field performance
The efficacy of live microorganisms depends on soil type, pH, temperature, moisture, resident microbial populations, crop variety and management practices. Products that perform well in trials can give inconsistent results across farms and seasons. This makes it harder for growers to justify repeat purchases, especially in low-margin broadacre crops where the value of a yield gain is small relative to the cost of the product.
Shelf life, viability and handling
Microbial products need minimum viable cell counts or propagule densities at the time of application. Storage temperature, time in the distribution channel and contact with incompatible agrochemicals, such as some seed-applied fungicides and copper-based products, can reduce viability. Meeting these requirements adds cost to formulation, packaging and logistics. It is a particular difficulty in hot climates and in markets with long, fragmented distribution chains.
Product quality and regulatory fragmentation
In several markets, weak enforcement of product standards has allowed low-quality or mislabelled biological products to be sold, which damages trust in the category. Regulatory definitions also differ between countries. Microbial soil conditioners may be regulated as fertilisers, biostimulants, soil amendments or plant protection products, depending on the jurisdiction and the claims made. This raises compliance costs for companies selling in multiple countries.
Showing growers a clear return on investment across a wide range of soils and climates, supported by independent multi-season trial data.
Competition from low-cost on-farm multiplication of microorganisms in some markets, notably Brazil, where farmers may produce bioinputs for their own use under the new bioinputs law.
Building agronomic advisory capacity, because the results of microbial products depend more on correct timing, placement and compatibility than those of conventional fertilisers.
Protecting intellectual property for naturally occurring microbial strains while meeting data requirements for registration in multiple jurisdictions.
Shift toward liquid formulations: Liquid products are projected to grow at 10.0%, against 8.7% for dry formats, as fertigation, drip irrigation and on-seed application spread.
Rising use of fungal products: Mycorrhizal inoculants and Trichoderma-based products are being adopted in mainstream field crops as well as horticulture. Fungal products are projected to reach 41.8% of the global market by 2032.
Consolidation and partnerships: Large crop-input companies are building biological portfolios through acquisitions and licensing. Examples include the formation of Novonesis (2024), Corteva's acquisitions of Symborg and Stoller (2023) and Biobest's acquisition of Biotrop in Brazil (2023).
On-farm production of bioinputs: In Brazil, the practice of farmers multiplying microorganisms on their own farms now has a formal legal basis. This is reshaping supply in the country's soybean, maize and sugarcane systems.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 112 companies operating in the Microbial Soil Conditioners Market market, including revenue, employee count, and market positioning where available.
Showing 112 of 112 companies
Company Headquarters: Indianapolis, US Founded: 1989 Workforce: ~21,100 Company Working: Corteva Agriscience develops, manufactures, and markets a wide range of products, including seeds and traits, crop protection, software, and digital solutions, seed treatments, forages, inoculants, vegetation management, pasture management, turf and ornamental, urban pest management, and oil. It is directly present in more than 50 countries and covers all major regions such as North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Corteva Agriscience is a subsidiary of Dow Chemical Company. Hence, the provided financial information is of the Dow Chemical Company.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
4 interactive charts drawn from the Microbial Soil Conditioners Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Microbial Soil Conditioners Market By Physical Form
Global Microbial Soil Conditioners Market By Crop Type
Global Microbial Soil Conditioners Market By Microorganism Type
Global Microbial Soil Conditioners Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
